06 Mar 2019 --- The boundless opportunities of the microbiome and the power of prebiotics and probiotics have given rise to intense focus from researchers, investors and companies working in both the nutraceutical and pharmaceutical space. However, what is becoming clear is the importance that claims stay rooted in science and not consumer hype. This is according to Stephen O’Hara, OptiBiotix CEO, who notes the emerging research on prebiotics and probiotics and the rising role they will have in the food and nutraceuticals industry in 2019.
